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Complications of Fluoroscopically Guided
Percutaneous Gastrostomy With Large-bore 
Balloon-retained Catheter in Patients With 
Head and Neck Tumors
Siu-Cheung Chan,1,5 Chiu-Wing Winnie Chu,2* Chun-Ta Liao,3 Kar-Wai Lui,1,5
Sheung-Fat Ko,4,5 Shu-Hang Ng1,5
Background/Purpose: To review the complications, mortality rate and nutritional status of patients with
head and neck cancer after fluoroscopically guided percutaneous gastrostomy (FPG).
Methods: We retrospectively recruited 110 patients who had undergone FPG using 14-French balloon-retained
catheters. The mortality rate, procedural and catheter-related complications, and Eastern Cooperative
Oncology Group performance status were reviewed. Peritonitis, abscess, septicemia and bleeding were defined
as major complications. Tube-related problems, including dislodgment, obstruction, leakage, vomiting
and infection, were classified as minor complications.
Results: Patients were stratified according to Eastern Cooperative Oncology Group performance status as
follows: grade 0 (n= 6); grade 1 (n= 22); grade 2 (n= 44); grade 3 (n= 29); and grade 4 (n= 7). The respective
complication rates were 21%, 24%, 26%, and 29% for grades 1–4; however, there were no significant inter-
grade differences. The rates of major and minor complications were 1.9% and 20.0%, respectively. A total of
47 (43.5%) patients succumbed due to cancer deterioration; however, there was no gastrostomy-induced
mortality. The catheter-occlusion rate of 3.7% in this cohort was significantly lower than that reported in
other pigtail-retained gastrostomy studies.
Conclusion: FPG is a safe method with low mortality and complication rate for constructing long-term
enteral access in patients with head and neck cancer and esophageal abnormalities, who have no endoscopic
access to the stomach.
Key Words: balloon-retained catheter, complication rate, fluoroscopically guided percutaneous gastrostomy,
head and neck cancer
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Cancer patients and those with dysphagia fre-
quently need nutritional support to improve their
nutritional status and reverse weight loss. Head
and neck cancer patients are generally identified
as a subgroup that might be helped by caloric sup-
plementation. Fluoroscopically guided percuta-
neous gastrostomy (FPG) is a currently acceptable
means of feeding patients with tumors of the head
and neck or esophagus, as well as those with neu-
rological or gastrointestinal disorders that hamper
normal oral intake.1,2 FPG was first described in
1983,3 and is a variation of radiological gastros-
tomy, with a longer catheter that extends from the
stomach to the proximal jejunum. FPG is per-
formed as a percutaneous procedure under fluor-
oscopic guidance and local anesthesia, and it has
a low rate of complications and a high rate of
technical success.4,5 Radiologically-guided place-
ment of gastrostomy tubes has a higher success
rate than endoscopic placement, although com-
plication and overall survival rates do not differ
significantly.6
The purpose of this study was to review the
complication and mortality rates in a sample pop-
ulation of head and neck cancer patients who
underwent FPG.
Materials and Methods
Patients, instruments and medications
The institutional review board of our hospital
approved this retrospective study. From November
2002 to February 2008, 110 patients (17 female, 93
male) underwent FPG at our institution, with the
procedure (n = 121) repeated once in nine cases
and twice in two cases, using 14-French balloon-
retained catheters (Balloon Replacement Tube,
PEG-BRT; Cook, Bloomington, IN, USA). All pa-
tients received 1 g intravenous ceftizoxime so-
dium for antibiotic prophylaxis (Cefizox, Fujisawa
Holland B.V. Houten, the Netherlands). In addition
to local anesthesia, the patients received intraven-
ous sedation with 5 mg midazolam (Dormicum;
Roche, Basel, Switzerland) and fentanyl citrate
(Sublimaze; Abbott Laboratories, North Chicago,
IL, USA). Oxygen saturation, blood pressure, and
heart rate and rhythm were monitored by noninva-
sive means. Intravenous hyoscine-N-butylbromide
(40 mg, Buscopan; Boehringer Ingelheim, Ingel-
heim, Germany) was administered before gastric
insufflation. Enteric contrast material for colonic
opacification and sonographic localization of the
left hepatic lobe were not routinely performed.
Balloon-retained catheter placement
The stomach was insufflated using a nasogastric
tube or a 4-French angiocatheter (the latter was
used for patients with high-grade narrowing of the
oropharynx, or cervical or thoracic esophagus).
The midbody of the stomach was punctured using
fluoroscopic guidance after subcutaneous admin-
istration of local anesthesia. Modified gastropexy
using two T-fasteners (Cope Gastrointestinal Suture
Anchor Set; Cook) were placed around the in-
tended catheter site. A 3–4-mm incision was made
in the center of the gastropexy fasteners, the stom-
ach was accessed through the incision, and the
tract was serially dilated to accept a 19-French,
peel-away introducer sheath (Figures A–C). A 14-
French balloon-retained catheter was then inserted
through the sheath into the stomach (n = 7/103)
(Figure D). The outer sheath of the peel-away in-
troducer sheath was removed (Figures E and F).
Finally, 5 mL water-soluble contrast medium (60%
iothalamate meglumine, Conray 60; Mallinckrodt
Canada, Pointe-Claire, Quebec, Canada) was in-
jected into the gastrostomy balloon until the bal-
loon was fully inflated (Figures G and H). Technical
success was checked fluoroscopically at the end
of the procedure with 10 mL water-soluble con-
trast medium injected via the feed port of the
catheter, to confirm that the gastrostomy catheter
was correctly placed within the stomach. The T-
fasteners were cut off 14 days after tube insertion.
Follow-up
All patients were followed up for 14, 30 and 60
days after the procedure, and every 90 days there-
after. The technical success, procedural and
catheter-related complications, cancer staging
(according to TNM classification), and baseline
Fluoroscopically guided percutaneous gastrostomy
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Figure. (A) Spot radiograph shows a T-fastener mounted inside an 18-G needle. An anchor was pushed into the stomach
via the 18-G puncture needle through the anterior gastric wall. (B) Spot radiograph shows a completed gastropexy using
two T-fasteners. (C) A 19-French peel-away introducer sheath was inserted through the percutaneous tract into the
stomach. (D) The peel-away sheath with coaxial balloon-retained catheter was inserted into the stomach. (E) The outer
sheath of the introducer was peeled off. (F) Photograph at completion of the procedure, with the outer retention plate
placed at the skin layer. (G) Spot radiograph after insertion of the peel-away sheath shows the gastrostomy catheter inside
the sheath and the balloon sufficiently inflated. (H) Spot radiograph shows the water-soluble contrast medium injected
via the feed port into the stomach to confirm the position of the gastrostomy catheter.
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and post-procedural body weight were recorded.
All relevant discharge summaries and laboratory
reports were reviewed. Peritonitis, abscess, sep-
ticemia and bleeding were defined as major com-
plications. Tube problems, such as dislodgment,
obstruction, leakage and infection, were defined
as minor complications. In addition, status with
respect to chronic disease (e.g. diabetes mellitus,
hypertension and renal dysfunction) and antibiotic
use were recorded. Patients were assessed accord-
ing to the Eastern Cooperative Oncology Group
(ECOG) performance status scale7 (Table 1) and in-
dication type. Two patients were lost to follow-up.
Results
The mean age of this cohort was 65.4 years.
Medical history of underlying diseases was as fol-
lows: diabetes mellitus (n = 25), hypertension
(n = 22) and renal disease (n = 17). Indications
were prophylactic placement of the tube because
we anticipated that the patients would have diffi-
culty in swallowing during and/or after treatment
(n = 41; 38%); poor nutrition (n = 27; 25%); and
inability to feed orally (n=40; 37%). Nine patients
underwent two gastrostomies and two underwent
three, with a successful outcome in 119 (98%) of
121 procedures. Patients were assessed for ECOG
performance status: grade 0 (n = 6); grade 1 (n =
22); grade 2 (n= 44); grade 3 (n= 29); and grade 4
(n= 7). A breakdown of major (1.9%) and minor
(19.4%) complications is presented in Table 2.
Two (1.9%) patients were cancer stage I, 26 (24%)
stage II, 30 (28%) stage III, 41 (38%) stage IV,
and nine (8.1%) were unclassified. The subjects
were also stratified according to decreased or in-
creased body weight into group A (n = 36; 33%)
or group B (n= 72; 67%), respectively, with mean
pre/post-treatment (12 months) values of 68.6 ±
3.4/62.2 ± 4.1 kg and 67.1 ± 2.5/79.6 ± 2.9 kg, re-
spectively. Mean hospital stay was 3.2 days for the
procedure. Forty-seven (43.5%) patients expired
due to cancer deterioration; however, there was no
gastrostomy-induced mortality. The interval from
gastrostomy to death ranged from 19 to 347 days.
Discussion
Fluoroscopically guided gastrostomy is typically
performed by stomach puncture, followed by se-
rial dilation of the puncture site, and advancement
Table 1. Eastern Cooperative Oncology Group performance status scale
Grade Status
0 Fully active, able to sustain all pre-disease activities without restriction
1 Restricted in physically strenuous activity but ambulatory and able to perform light/sedentary work 
(e.g. light household duties or office work)
2 Ambulatory and capable of all self-care but unable to perform any work activities. Up and about for 
> 50% of waking hours
3 Capable of only limited self-care, confined to bed/chair > 50% of waking hours
4 Completely disabled. Unable to provide any self-care. Totally confined to bed or chair
5 Died
Table 2. Complications in head and neck tumor
patients after fluoroscopically guided
percutaneous gastrostomy (n = 108)
Type of complication n (%)
Major
Peritonitis 1
Abscess 0
Septicemia 0
Bleeding 1
Total 2 (1.9)
Minor
Tube dislodgement 7
Tube obstruction 4
Tube leakage 7
Infection 3
Total 21 (19.4)
Fluoroscopically guided percutaneous gastrostomy
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of a pigtail/balloon-retained catheter into the
stomach over a guide wire. Smaller pigtail-retained
catheters are inserted directly, whereas large-bore
balloon-retained tubes are inserted via a peel-
away sheath or in tandem with a leading angio-
plasty balloon.8 This technique is straightforward
and has recently been used for tube insertion in
patients with obstructing head and neck or esoph-
ageal carcinomas. There are also potential advan-
tages of FPG over PEG (percutaneous endoscopic
gastrostomy). In patients who have head and neck
or esophageal cancer with high-grade narrowing
of the oropharynx and/or upper esophagus, there
is no endoscopic access to the stomach. In some
patients who have received surgery, such as wide
neck dissection or subtotal mandibulectomy, en-
doscopy might destroy the reconstructed flaps
and grafts in the head and neck regions, there-
fore, FPG serves as an alternative. FPG can be
performed by a single radiologist, whereas more
operators are required for the surgical and endo-
scopic approaches. Only local sedation is required
for FPG, in contrast to the general anesthesia which
is required for the surgical procedures.
In agreement with other studies, we found that
percutaneous gastrostomy had a high success rate
when compared with endoscopic and surgical gas-
trostomy. In consideration of cost, endoscopic and
fluoroscopic gastrostomies are similar but the sur-
gical approach is significantly more expensive.
In this study of FPG, the technical success,
complication and mortality rates were similar to
those in other studies of surgical, endoscopic and
fluoroscopic tube placement. In our study, there
was no procedure-related mortality, and major
and minor complications occurred in 1.9% and
19.4%, respectively, compared with 1.6–1.9%
and 15–22% in other studies with fluoroscopic
tube placement,2,10.13 whereas the major compli-
cation rates could be up to 19–25% and 3–7%
for surgical and endoscopic approaches, respec-
tively.11–15 The range of reported minor compli-
cations also reached 29–35% and 13–24% for
the latter two procedures.
In this study, balloon-retained catheters 
were used instead of pigtail-retained catheters,
and we demonstrated similar major and minor
complication rates compared with those in the
study of Baere et al (1.4% and 21%, respectively).9
However, the occlusion rate of balloon-retained
catheters was much lower in our study. We pos-
tulated that this disparity might be because of
the larger end-aperture used for balloon-retained
gastrostomy compared with the side-hole in the
pigtail variant; hence, the incidence of occlusion
was reduced in the former method.
The results of previous investigations reflect
the significance of associated illness in terms of el-
evated mortality rate.2,10 In a similar study in which
head and neck cancer patients were recruited,
Ryan et al10 did not take into consideration the co-
morbidity of their patients. Similarly, in the study
of Halkier et al, there were no specific exclusion
criteria to avoid any confounding effect of co-
morbidity on mortality rate.2 In our cohort of
110 patients, 47 died during the follow-up period;
all of those cases related to cancer deterioration,
without gastrostomy-related problems. Our obser-
vations suggest that the mortality rate related to
FPG is probably minimal.
The present study demonstrates that cancer
staging might be an index for complication rate.
The two patients with major complications were
stage III and IV, whereas the patients with minor
complications were stage II (n= 2), III (n= 17) and
IV (n = 3). Cancer stage appears to be associated
with complication rate. In a previous study,
Wollman et al found that 75% of patients with
FPG-induced complications had stage III and IV
cancer.16 Funaki et al divided their patients into
two groups based on cancer stage (≤ II or > II), with
respective complication rates of 14% and 86%.17
Our complication rates for groups stratified ac-
cording to the above criteria (8.3% and 91.7%)
were comparable.
Body weight is a common indicator for nutri-
tional status. In the present cohort, body weight
increased in 67% of our patients, and although
the body weight of group A had decreased after 
1 year, there was no significant difference com-
pared with baseline. In contrast, the body weight
of group B significantly increased from baseline
S.C. Chan, et al
608 J Formos Med Assoc | 2010 • Vol 109 • No 8
at 12 months. It appears reasonable to suggest,
therefore, that the net effect of gastrostomy on
body weight is positive.
In an analysis of the relationships with com-
plication rate, McLoughlin and Gibney demon-
strated that ECOG performance status and illness
are the two most accurate predictors for compli-
cation rate.5 Pitman et al demonstrated that ECOG
performance status was the best reference for clin-
ical physicians for selection of appropriate treat-
ment; however, relative data were not supplied.19
In our cohort, the relationship between ECOG
performance and complication rate was not ap-
parent, and this might be explained by the multi-
variate nature of the complication rate.
In conclusion, we recommend FPG as the
method of choice for catheter insertion in pa-
tients with advanced head and neck cancers with
no endoscopic access to the stomach. FPG is a
safe and simple method with low mortality and
complication rates for constructing enteral access
for nutritional supplement before, during and
after treatment. Balloon-retained gastrostomy is
the recommended choice of catheter, with a low
rate of occlusion.
References
1. Brown AS, Mueller PR, Ferrucci JT. Controlled percuta-
neous gastrostomy nylon T-fastener for fixation of the an-
terior gastric wall. Radiology 1986;158:543–5.
2. Halkier BK, Ho CS, Yee, AC. Percutaneous feeding gas-
trostomy with the Seldinger technique: review of 252 pa-
tients. Radiology 1989;171:359–62.
3. Ho CS. Percutaneous gastrostomy for jejunal feeding.
Radiology 1983;149:595–6.
4. Bell SD, Carmody EA. Percutaneous gastrostomy and gas-
trojejunostomy: additional experience in 519 procedures.
Radiology 1995;194:817–20.
5. McLoughlin RF, Gibney RG. Fluoroscopically guided per-
cutaneous gastrostomy: tube function and malfunction.
Abdom Imaging 1994;19:195–200.
6. Thornton FJ, Fotheringham T. Amytrophic lateral sclerosis:
enteral nutrition provision—endoscopic or radiologic gas-
trostomy? Radiology 2002;224:713–7.
7. Oken MM, Creech RH, Tormey DC, et al. Toxicity and 
response criteria of the Eastern Cooperative Oncology
Group. Am J Clin Oncol 1982;5:649–55.
8. Trerotola SO, Shah H, Johnson MS, et al. Single-step dila-
tion for large-bore percutaneous gastrostomy and gastro-
jejunostomy. J Vasc Interv Radiol 1998;9:579–82.
9. Barkmeier JM, Trerotola SO, Wiebke EA, et al. Percutaneous
radiologic surgical endoscopic and percutaneous endo-
scopic gastrostomy/gastrojejunostomy: Comparative study
and cost analysis. Cardiovasc Intervent Radiol 1998;21:
324–8.
10. Ryan JM, Hahn PF, Boland GW. Percutaneous gastrostomy
with T-fastener gastropexy: results of 316 consecutive
procedures. Radiology 1997;203:496–500.
11. Wollman B, Dagostino HB. Percutaneous radiologic and
endoscopic gastrostomy: a 3-year institutional analysis of
procedure performance. AJR Am J Roentgenol 1997;169:
1551–3.
12. Ho CS, Yee AC, McPherson R. Complications of surgical
and percutaneous nonendoscopic gastrostomy: review of
233 patients. Gastroenterology 1988;95:1206–10.
13. Scott JS, de la Torre RA, Under SW. Comparison of opera-
tive versus percutaneous endoscopic gastrostomy tube
placement in the elderly. Am Surg 1991;57:338–40.
14. Larson DE, Burton DD. Percutaneous endoscopic gastros-
tomy: indications, success, complications, and mortality 
in 314 consecutive patients. Gastroenterology 1987;93:
48–52.
15. Potack JZ, Chokhavatia S. Complications of and controver-
sies associated with percutaneous endoscopic gastros-
tomy: Report of a case and literature review. Medscape J
Med 2008;10:142.
16. Baere TD, Chapot R, Kuoch V, et al. Percutaneous gastros-
tomy with fluoroscopic guidance: single-center experience
in 500 consecutive cancer patients. Radiology 1999;210:
651–4.
17. Wollman BD, Agostino HB, Walus-Wigle JR. Radiologic,
endoscopic and surgical gastrostomy: an institutional eval-
uation and meta-analysis of the literature. Radiology
1995;197:699–704.
18. Funaki B, Zaleski GX, Lorenz J. Radiologic gastrostomy
placement: mushroom versus pigtail catheters. AJR Am J
Roentgenol 2000;175:375–9.
19. Pitman AG, Lau PHC, Lau WFE, et al. Fluoroscopically
guided percutaneous radiological gastrostomy: technique,
methodology and pitfalls. Australas Radiol 2003;47:205–12.
